Eloctate (Antihemophilic factor [recombinant], Fc fusion protein)
Overview Eloctate is approved by the Food and Drug Administration (FDA) to control and prevent bleeding episodes in children and adults with factor VIII deficiency due to hemophilia A. Eloctate can also be used for… read more